BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33036902)

  • 1. Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
    Hajiran A; Zemp L; Aydin AM; Cheryian SK; Pow-Sang JM; Chahoud J; Spiess PE
    Urol Oncol; 2021 Jan; 39(1):72.e1-72.e5. PubMed ID: 33036902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.
    Alnajjar HM; Lam W; Bolgeri M; Rees RW; Perry MJ; Watkin NA
    Eur Urol; 2012 Nov; 62(5):923-8. PubMed ID: 22421082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of intraepithelial penile carcinoma with imiquimod.
    Micali G; Nasca MR; Tedeschi A
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():4-6. PubMed ID: 14616802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
    Schroeder TL; Sengelmann RD
    J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recalcitrant squamous carcinoma in situ of penis with tapering imiquimod 5-3.75% cream.
    Caposiena Caro RD; Di Prete M; Didona D; Sechi A; Orlandi A; Bianchi L
    Dermatol Ther; 2019 May; 32(3):e12904. PubMed ID: 30964593
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
    Zhang S; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroplasia of Queyrat treated with topical 5-fluorouracil.
    Antônio JR; Antônio CR; Trídico LA; Alves FT; Rollemberg I
    An Bras Dermatol; 2016; 91(5 suppl 1):42-44. PubMed ID: 28300890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision.
    Torelli T; Catanzaro MA; Nicolai N; Giannatempo P; Necchi A; Raggi D; Paolini B; Colecchia M; Piva L; Biasoni D; Stagni S; Tesone A; Salvioni R
    Clin Genitourin Cancer; 2017 Jun; 15(3):e483-e487. PubMed ID: 28209454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
    Orengo I; Rosen T; Guill CK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S225-8. PubMed ID: 12271283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroplasia of Queyrat: treatment with topical 5-fluorouracil.
    Goette DK; Carson TE
    Cancer; 1976 Oct; 38(4):1498-502. PubMed ID: 991073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network.
    Lucky M; Murthy KV; Rogers B; Jones S; Lau MW; Sangar VK; Parr NJ
    BJU Int; 2015 Apr; 115(4):595-8. PubMed ID: 25060513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod in the treatment of penile intraepithelial neoplasia: An update.
    Deen K; Burdon-Jones D
    Australas J Dermatol; 2017 May; 58(2):86-92. PubMed ID: 26952903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroplasia of Queyrat.
    Goette DK
    Arch Dermatol; 1974 Aug; 110(2):271-3. PubMed ID: 4851903
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Bowen's disease of the penis with imiquimod 5% cream.
    Danielsen AG; Sand C; Weismann K
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():7-9. PubMed ID: 14616803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
    Hurt CN; Jones S; Madden TA; Fiander A; Nordin AJ; Naik R; Powell N; Carucci M; Tristram A
    BJOG; 2018 Aug; 125(9):1171-1177. PubMed ID: 29336101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Ondo AL; Mings SM; Pestak RM; Shanler SD
    J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowen's disease of the penis treated with topical imiquimod 5% cream.
    Taliaferro SJ; Cohen GF
    J Drugs Dermatol; 2008 May; 7(5):483-5. PubMed ID: 18505144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.